Molecular profiling of embryonal carcinoma cells following retinoic acid or histone deacetylase inhibitor treatment

Cancer Biology and Therapy

Volumn 3, Issue 11, 2004, Pages 1109-1120

  Sangster Guity, Niquiche ^a   Yu, Li Ming ^a   McCormick, Paulette ^a,b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b STRATTON VA MEDICAL CENTER   (United States)

Author keywords

Embryonal carcinoma; Genomatix; HDAC inhibitor; Oligonucleotide microarray; Promoter module; Retinoic acid; Trichostatin A

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA1; TRICHOSTATIN A; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; HISTONE DEACETYLASE; HYDROXAMIC ACID; TUMOR MARKER;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CANCER CELL; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYONAL CARCINOMA; GENE; GENE CLUSTER; GENE EXPRESSION; GENE TARGETING; GENETIC ANALYSIS; GENETIC REGULATION; MOUSE; NONHUMAN; PARAMETER; PROMOTER REGION; PROTEIN MOTIF; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE; CANCER STEM CELL; CELL CULTURE; DNA MICROARRAY; DRUG ANTAGONISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PATHOLOGY;

ANTINEOPLASTIC AGENTS; CARCINOMA, EMBRYONAL; ENZYME INHIBITORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRETINOIN; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELLS;

EID: 22144465890     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.11.1190     Document Type: Article

References (77)

1. Sun SY, Lotan R. Retinoids and their receptors in cancer development and chemoprevention. Crit Rev Oncol Hematol 2002; 41:41-55.
2. Degos L, Wang ZY. All trans retinoic acid in acute promyelocytic leukemia. Oncogene 2001; 20:7140-5.
3. Sporn MB, Roberts AB, Goodman DS. The retinoids: Biology, chemistry, and medicine. 2nd ed. New York: Raven Press, 1994.
4. Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 2000; 14:121-41.
5. Johnstone RW. Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer. Nat Rev Drug Discov 2002; 1:287-99.
6. Marks PA, Richon VM, Breslow R, Rifkind RA. Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol 2001; 13:477-83.
7. Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 2000; 92:1210-6.
8. Marks PA, Rifkind RA, Richon VM, Breslow R. Inhibitors of histone deacetylase are potentially effective anticancer agents. Clin Cancer Res 2001; 7:759-60.
9. Warrell Jr RP, He LZ, Richon V, Calleja E, Pandolfi PP. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst 1998; 90:1621-5.
10. Ferrara FF, Fazi F, Bianchini A, Padula F, Gelmetti V, Minucci S, et al. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. Cancer Res 2001; 61:2-7.
11. Martin GR. Teratocarcinomas as a model system for the study of embryogenes is and neoplasia. Cell 1975; 5:229-43.
12. Miyashita T, Yamamoto H, Nishimune Y, Nozaki M, Morita T, Matsushiro A. Activation of the mouse cytokeratin a (endo a) gene in teratocarcinoma f9 cells by the histone deacetylase inhibitor trichostatin a. FEBS Lett 1994; 353:225-9.
13. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 1999; 286:531-7.
14. Scherf M, Klingenhoff A, Werner T. Highly specific localization of promoter regions in large genomic sequences by promoterinspector: A novel context analysis approach. J Mol Biol 2000; 297:599-606.
15. Frech K, Danescu-Mayer J, Werner T. A novel method to develop highly specific models for regulatory units detects a new ltr in genbank which contains a functional promoter. J Mol Biol 1997; 270:674-87.
16. Quandt K, Frech K, Karas H, Wingender E, Werner T. Matind and matinspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995; 23:4878-84.
17. Hughes JD, Estep PW, Tavazoie S, Church GM. Computational identification of cis-regulatory elements associated with groups of functionally related genes in saccharomyces cerevisiae. J Mol Biol 2000; 296:1205-14.
18. Koopman P, Cotton RG. Pluripotent differentiation of single f9 embryonal carcinoma cells. Exp Cell Res 1987; 168:567-71.
19. Edgar R, Domrachev M, Lash AE. Gene expression omnibus: Ncbi gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30:207-10.
20. Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, Valmeekam V, et al. Netaffx: Affymetrix probesets and annotations. Nucleic Acids Res 2003; 31:82-6.
21. Yost HJ. Establishment of left-right asymmetry. Int Rev Cytol 2001; 203:357-381.
22. Moustakas A, Pardali K, Gaal A, Heldin CH. Mechanisms of tgf-β signaling in regulation of cell growth and differentiation. Immunol Lett 2002; 82:85-91.
23. Werner T. Target gene identification from expression array data by promoter analysis. Biomol Eng 2001; 17:87-94.
24. Baulande S, Lasnier F, Lucas M, Pairault J. Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mrna specifically expressed in the adipose lineage. J Biol Chem 2001; 276:33336-44.
25. Oulad-Abdelghani M, Chazaud C, Bouillet P, Mattei MG, Dolle P, Chambon P. Stra3/lefty, a retinoic acid-inducible novel member of the transforming growth factor-β superfamily. Int J Dev Biol 1998; 42:23-32.
26. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, et al. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia. Nature 1998; 391:815-8.
27. Kelly DL, Rizzino A. DNA microarray analyses of genes regulated during the differentiation of embryonic stem cells. Mol Reprod Dev 2000; 56:113-23.
28. Loring JF, Porter JG, Seilhammer J, Kaser MR, Wesselschmidt R. A gene expression profile of embryonic stem cells and embryonic stem cell-derived neurons. Restor Neurol Neurosci 2001; 18:81-8.
29. Harris TM, Childs G. Global gene expression patterns during differentiation of f9 embryonal carcinoma cells into parietal endoderm. Funct Integr Genomics 2002; 2:105-19.
30. Wei Y, Harris T, Childs G. Global gene expression patterns during neural differentiation of p19 embryonic carcinoma cells. Differentiation 2002; 70:204-19.
31. Satoh J, Kuroda Y. Differential gene expression between human neurons and neuronal progenitor cells in culture: An analysis of arrayed cdna clones in ntera2 human embryonal carcinoma cell line as a model system. J Neurosci Methods 2000; 94:155-64.
32. Bani-Yaghoub M, Felker JM, Ozog MA, Bechberger JF, Naus CC. Array analysis of the genes regulated during neuronal differentiation of human embryonal cells. Biochem Cell Biol 2001; 79:387-98.
33. Leypoldt F, Lewerenz J, Methner A. Identification of genes up-regulated by retinoic-acid-induced differentiation of the human neuronal precursor cell line ntera-2 cl.D1. J Neurochem 2001; 76:806-14.
34. Mariadason JM, Arango D, Corner GA, Aranes MJ, Hotchkiss KA, Yang W, et al. A gene expression profile that defines colon cell maturation in vitro. Cancer Res 2002; 62:4791-804.
35. He LZ, Tolentino T, Grayson P, Zhong S, Warrell Jr RP, Rifkind RA, et al. Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. J Clin Invest 2001; 108:1321-30.
36. McCormick PJ, Shin HS. Analysis of a nontumorigenic embryonal carcinoma cell line. Exp Cell Res 1990; 189:183-8.
37. Inohara N, Koseki T, Chen S, Wu X, Nunez G. Cide, a novel family of cell death activators with homology to the 45 kda subunit of the DNA fragmentation factor. EMBO J 1998; 17:2526-33.
38. Maecker HT, Todd SC, Levy S. The tetraspanin superfamily: Molecular facilitators. Faseb J 1997; 11:428-42.
39. Spengler D, Villalba M, Hoffmann A, Pantaloni C, Houssami S, Bockaert J, et al. Regulation of apoptosis and cell cycle arrest by zac1, a novel zinc finger protein expressed in the pituitary gland and the brain. EMBO J 1997; 16:2814-25.
40. Baxter RC. Signalling pathways involved in antiproliferative effects of igfbp-3: A review. Mol Pathol 2001; 54:145-8.
41. Rickles RJ, Darrow AL, Strickland S. Molecular cloning of complementary DNA to mouse tissue plasminogen activator mrna and its expression during f9 teratocarcinoma cell differentiation. J Biol Chem 1988; 263:1563-9.
42. Kwiatkowski DJ. Predominant induction of gelsolin and actin-binding protein during myeloid differentiation. J Biol Chem 1988; 263:13857-62.
43. De Bruin A, Muller E, Wurm S, Caldelari R, Wyder M, Wheelock MJ, et al. Loss of invasiveness in squamous cell carcinoma cells overexpressing desmosomal cadherins. Cell Adhes Commun 1999; 7:13-28.
44. Buckbinder L, Talbott R, VelascoMiguel S, Takenaka I, Faha B, Seizinger BR, et al. Induction of the growth inhibitor igf-binding protein 3 by p53. Nature 1995; 377:646-9.
45. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, et al. Direct functional interactions between insulin-like growth factor- binding protein-3 and retinoid x receptor-α regulate transcriptional signaling and apoptosis. J Biol Chem 2000; 275:33607-13.
46. Dieffenbach CW, SenGupta DN, Krause D, Sawzak D, Silverman RH. Cloning of murine gelsolin and its regulation during differentiation of embryonal carcinoma cells. J Biol Chem 1989; 264:13281-8.
47. Fujita M, Furukawa Y, Tsunoda T, Tanaka T, Ogawa M, Nakamura Y. Up-regulation of the ectodermal-neural cortex 1 (enc1) gene, a downstream target of the β-catenin/t-cell factor complex, in colorectal carcinomas. Cancer Res 2001; 61:7722-6.
48. Okuda A, Fukushima A, Nishimoto M, Orimo A, Yamagishi T, Nabeshima Y, et al. Utf1, a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extra-embryonic cells. EMBO J 1998; 17:2019-32.
49. Oh IH, Reddy EP. The myb gene family in cell growth, differentiation and apoptosis. Oncogene 1999; 18:3017-33.
50. Liguori G, Tucci M, Montuori N, Dono R, Lago CT, Pacifico F, et al. Characterization of the mouse tdgf1 gene and tdgf pseudogenes. Mamm Genome 1996; 7:344-8.
51. Yanagisawa H, Nagasawa T, Kuramochi S, Abe T, Ikawa Y, Todokoro K. Constitutive expression of exogenous c-myb gene causes maturation block in monocyte- macrophage differentiation. Biochim Biophys Acta 1991; 1088:380-4.
52. Kwiatkowski DJ. Functions of gelsolin: Motility, signaling, apoptosis, cancer. Curr Opin Cell Biol 1999; 11:103-8.
53. Asch HL, Winston JS, Edge SB, Stomper PC, Asch BB. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion. Breast Cancer Res Treat 1999; 55:179-88.
54. Mielnicki LM, Ying AM, Head KL, Asch HL, Asch BB. Epigenetic regulation of gelsolin expression in human breast cancer cells. Exp Cell Res 1999; 249:161-76.
55. Habeck M. Gelsolin: A new marker for breast cancer? Mol Med Today 1999; 5:503.
56. Niemeyer CC, Persico MG, Adamson ED. Cripto: Roles in mammary cell growth, survival, differentiation and transformation. Cell Death Differ 1998; 5:440-9.
57. Hanna LA, Foreman RK, Tarasenko IA, Kessler DS, Labosky PA. Requirement for foxd3 in maintaining pluripotent cells of the early mouse embryo. Genes Dev 2002; 16:2650-61.
58. Ozisik G, Achermann JC, Jameson JL. The role of sf1 in adrenal and reproductive function: Insight from naturally occurring mutations in humans. Mol Genet Metab 2002; 76:85-91.
59. Matsumoto N, Yoneda-Kato N, Iguchi T, Kishimoto Y, Kyo T, Sawada H, et al. Elevated mlf1 expression correlates with malignant progression from myelodysplastic syndrome. Leukemia 2000; 14:1757-65.
60. Ferrari S, Calabretta B, Selleri L, Ceccherelli G, Torelli G, Torelli U. Expression of oncogenes and cell cycle related genes in acute and chronic leukemias. Leukemia 1988; 2:160S-6S.
61. Kondos H, Anastasiadou E, Photopoulou A, Cary P, Aleporou-Marinou V, Pataryas T. Elevated levels of the chromosomal protein hmg 17 in chronic myelogenic leukemia. Biochem Mol Biol Int 1995; 36:803-9.
62. King T, Brown NA. Embryonic asymmetry: The left side gets all the best genes. Curr Biol 1999; 9:R18-22.
63. Toyota M, Kopecky KJ, Toyota MO, Jair KW, Willman CL, Issa JP. Methylation profiling in acute myeloid leukemia. Blood 2001; 97:2823-9.
64. Akhurst RJ, Derynck R. Tgf-β signaling in cancer - a double-edged sword. Trends Cell Biol 2001; 11:S44-51.
65. Senyuk V, Chakraborty S, Mikhail FM, Zhao R, Chi Y, Nucifora G. The leukemia-associated transcription repressor aml1/mds1/evil requires ctbp to induce abnormal growth and differentiation of murine hematopoietic cells. Oncogene 2002; 21:3232-40.
66. Izutsu K, Kurokawa M, Imai Y, Maki K, Mitani K, Hirai H. The corepressor ctbp interacts with evi-1 to repress transforming growth factor β signaling. Blood 2001; 97:2815-22.
67. Scherrer SP, Rice DA, Heckert LL. Expression of steroidogenic factor 1 in the testis requires an interactive array of elements within its proximal promoter. Biol Reprod 2002; 67:1509-21.
68. Cheng CK, Hoo RL, Chow BK, Leung PC. Functional cooperation between multiple regulatory elements in the untranslated exon 1 stimulates the basal transcription of the human gnrh-ii gene. Mol Endocrinol 2003; 27:27.
69. Olson JM, Asakura A, Snider L, Hawkes R, Strand A, Stoeck J, et al. Neurod2 is necessary for development and survival of central nervous system neurons. Dev Biol 2001; 234:174-87.
70. Farah MH, Olson JM, Sucic HB, Hume RI, Tapscott SJ, Turner DL. Generation of neurons by transient expression of neural bhlh proteins in mammalian cells. Development 2000; 127:693-702.
71. Tanaka M, Kijima H, Itoh J, Matsuda T, Tanaka T Impaired expression of a human septin family gene bradeion inhibits the growth and tumorigenesis of colorectal cancer in vitro and in vivo. Cancer Gene Ther 2002; 9:483-8.
72. Larisch S, Yi Y, Lotan R, Kerner H, Eimerl S, Tony Parks W, et al. A novel mitochondrial septin-like protein, arts, mediates apoptosis dependent on its p-loop motif. Nat Cell Biol 2000; 2:915-21.
73. Matern H, Heinemann H, Legler G, Matern S. Purification and characterization of a microsomal bile acid β- glucosidase from human liver. J Biol Chem 1997; 272:11261-7.
74. Kitamura T, Miyachi T, Nakamura S, Kawakami H. Identification and analysis of the promoter region of the human neurod- related factor (ndrf)1. Biochim Biophys Acta 1999; 1445:142-7.
75. MacDonald RJ, Swift GH, Quinto C, Swain W, Pictet RL, Nikovits W, et al. Primary structure of two distinct rat pancreatic preproelastases determined by sequence analysis of the complete cloned messenger ribonucleic acid sequences. Biochemistry 1982; 21:1453-63.
76. Antoniou AN, Ford S, Alphey M, Osborne A, Elliott T, Powis SJ. The oxidoreductase erp57 efficiently reduces partially folded in preference to fully folded mhc class i molecules. EMBO J 2002; 21:2655-63.
77. Ornitz DM, Hammer RE, Davison BL, Brinster RL, Palmiter RD. Promoter and enhancer elements from the rat elastase i gene function independently of each other and of heterologous enhancers. Mol Cell Biol 1987; 7:3466-72.